Category

• Business2
• Archives1

Organizations

• Bausch + Lomb64
• Eyes On Eyecare42
• Alcon, Inc.41
• American Optometric Association34
• Harrow26
• Glaukos25
• Regeneron21
• Aldeyra Therapeutics20
• Sight Sciences19
• American Academy Of Ophthalmology18

Tags

• Acquisitions2
• Products2
• AMD1
• DME1
• Diabetic Retinopathy1
• Retina1
• Retinal Vein Occlusion (rvo)1
• Wet Amd1

• Organizations: Coherus Biosciences✕

Clear all

Business

Sandoz completes acquisition of Coherus's ranibizumab biosimilar

Company looks to continue expanding its ophthalmology portfolio.

Business

Coherus is selling off its ophthalmology franchise to Sandoz

The $170 million deal includes the CIMERLI ophthalmology franchise, an interchangeable biosimilar of LUCENTIS.

Archives

Is there a cheaper version of Lucentis? — Weekly Glance

Good timing! The FDA just approved a comparable biosimilar.